IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Engene Therapeutics Inc

CUSIP: 29286X119 | 12 institutional holders

Quarters

Q3 2026Q2 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Wolverine Asset Management LLC1,344
0.0% of portfolio›$269
StyleTurnoverLocationFiled
Wolverine Asset Management LLC
1,344$2690.0%Deep ValueVery HighChicago, IL2026-11-02